Gap 27 (trifluoroacetate salt)
(Synonyms: 43Gap27, SRPTEKTIFII) 目录号 : GC49416A connexin-mimetic peptide
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Gap 27 is a connexin-mimetic peptide that corresponds to amino acids 204-214 of extracellular loop 2 in connexin 43.1 It reduces survival of isolated rat osteoclasts when used at a concentration of 500 µM and decreases bone resorption in rat bone slice and osteoclast co-cultures.2 Gap 27 accelerates wound closure and stratification of the corneal epithelium in isolated human corneas.3 In vivo, Gap 27 reduces cardiac remodeling and the incidence of cardiac arrhythmias in a rat model of arterio-venous fistula (AV-shunt) surgery-induced high-output heart failure.4
1.Wright, C.S., Pollok, S., Flint, D.J., et al.The connexin mimetic peptide Gap27 increases human dermal fibroblast migration in hyperglycemic and hyperinsulinemic conditions in vitroJ. Cell. Physiol.227(1)77-87(2012) 2.Ilvesaro, J., Tavi, P., and Tuukkanen, J.Connexin-mimetic peptide Gap 27 decreases osteoclastic activityBMC Musculoskelet. Disord.210(2001) 3.Elbadawy, H.M., Mirabelli, P., Xeroudaki, M., et al.Effect of connexin 43 inhibition by the mimetic peptide Gap27 on corneal wound healing, inflammation and neovascularizationBr. J. Pharmacol.173(19)2880-2893(2016) 4.Lucero, C.M., Andrade, D.C., Toledo, C., et al.Cardiac remodeling and arrhythmogenesis are ameliorated by administration of Cx43 mimetic peptide Gap27 in heart failure ratsSci. Rep.10(1)6878(2020)
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 0.7665 mL | 3.8326 mL | 7.6652 mL |
5 mM | 0.1533 mL | 0.7665 mL | 1.533 mL |
10 mM | 0.0767 mL | 0.3833 mL | 0.7665 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。